Global Osteoarthritis Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Osteoarthritis Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Osteoarthritis Gene Therapy industry chain, the market status of Hospitals and clinics (Synovium Injection, Cartilage Injection), Orthopedic Centers (Synovium Injection, Cartilage Injection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Osteoarthritis Gene Therapy.

Regionally, the report analyzes the Osteoarthritis Gene Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Osteoarthritis Gene Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Osteoarthritis Gene Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Osteoarthritis Gene Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Synovium Injection, Cartilage Injection).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Osteoarthritis Gene Therapy market.

Regional Analysis: The report involves examining the Osteoarthritis Gene Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Osteoarthritis Gene Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Osteoarthritis Gene Therapy:
Company Analysis: Report covers individual Osteoarthritis Gene Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Osteoarthritis Gene Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and clinics, Orthopedic Centers).

Technology Analysis: Report covers specific technologies relevant to Osteoarthritis Gene Therapy. It assesses the current state, advancements, and potential future developments in Osteoarthritis Gene Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Osteoarthritis Gene Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Osteoarthritis Gene Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Synovium Injection
    Cartilage Injection

Market segment by Application
    Hospitals and clinics
    Orthopedic Centers
    Assisted living Facilities
    Nursing Homes
    Ambulatory Surgical Centers
    Others

Market segment by players, this report covers
    Flexion
    GeneQuine
    Novartis
    Smith & Nephew
    Genascence
    Kolon TissueGene
    Sanofi
    Paraxel
    Medipost
    Mundipharma

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Osteoarthritis Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Osteoarthritis Gene Therapy, with revenue, gross margin and global market share of Osteoarthritis Gene Therapy from 2019 to 2024.
Chapter 3, the Osteoarthritis Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Osteoarthritis Gene Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Osteoarthritis Gene Therapy.
Chapter 13, to describe Osteoarthritis Gene Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Osteoarthritis Gene Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Osteoarthritis Gene Therapy by Type
        1.3.1 Overview: Global Osteoarthritis Gene Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Osteoarthritis Gene Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Synovium Injection
        1.3.4 Cartilage Injection
    1.4 Global Osteoarthritis Gene Therapy Market by Application
        1.4.1 Overview: Global Osteoarthritis Gene Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals and clinics
        1.4.3 Orthopedic Centers
        1.4.4 Assisted living Facilities
        1.4.5 Nursing Homes
        1.4.6 Ambulatory Surgical Centers
        1.4.7 Others
    1.5 Global Osteoarthritis Gene Therapy Market Size & Forecast
    1.6 Global Osteoarthritis Gene Therapy Market Size and Forecast by Region
        1.6.1 Global Osteoarthritis Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Osteoarthritis Gene Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Osteoarthritis Gene Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Osteoarthritis Gene Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Osteoarthritis Gene Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Osteoarthritis Gene Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Osteoarthritis Gene Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Flexion
        2.1.1 Flexion Details
        2.1.2 Flexion Major Business
        2.1.3 Flexion Osteoarthritis Gene Therapy Product and Solutions
        2.1.4 Flexion Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Flexion Recent Developments and Future Plans
    2.2 GeneQuine
        2.2.1 GeneQuine Details
        2.2.2 GeneQuine Major Business
        2.2.3 GeneQuine Osteoarthritis Gene Therapy Product and Solutions
        2.2.4 GeneQuine Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 GeneQuine Recent Developments and Future Plans
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Osteoarthritis Gene Therapy Product and Solutions
        2.3.4 Novartis Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Novartis Recent Developments and Future Plans
    2.4 Smith & Nephew
        2.4.1 Smith & Nephew Details
        2.4.2 Smith & Nephew Major Business
        2.4.3 Smith & Nephew Osteoarthritis Gene Therapy Product and Solutions
        2.4.4 Smith & Nephew Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Smith & Nephew Recent Developments and Future Plans
    2.5 Genascence
        2.5.1 Genascence Details
        2.5.2 Genascence Major Business
        2.5.3 Genascence Osteoarthritis Gene Therapy Product and Solutions
        2.5.4 Genascence Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Genascence Recent Developments and Future Plans
    2.6 Kolon TissueGene
        2.6.1 Kolon TissueGene Details
        2.6.2 Kolon TissueGene Major Business
        2.6.3 Kolon TissueGene Osteoarthritis Gene Therapy Product and Solutions
        2.6.4 Kolon TissueGene Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Kolon TissueGene Recent Developments and Future Plans
    2.7 Sanofi
        2.7.1 Sanofi Details
        2.7.2 Sanofi Major Business
        2.7.3 Sanofi Osteoarthritis Gene Therapy Product and Solutions
        2.7.4 Sanofi Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Sanofi Recent Developments and Future Plans
    2.8 Paraxel
        2.8.1 Paraxel Details
        2.8.2 Paraxel Major Business
        2.8.3 Paraxel Osteoarthritis Gene Therapy Product and Solutions
        2.8.4 Paraxel Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Paraxel Recent Developments and Future Plans
    2.9 Medipost
        2.9.1 Medipost Details
        2.9.2 Medipost Major Business
        2.9.3 Medipost Osteoarthritis Gene Therapy Product and Solutions
        2.9.4 Medipost Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Medipost Recent Developments and Future Plans
    2.10 Mundipharma
        2.10.1 Mundipharma Details
        2.10.2 Mundipharma Major Business
        2.10.3 Mundipharma Osteoarthritis Gene Therapy Product and Solutions
        2.10.4 Mundipharma Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Mundipharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Osteoarthritis Gene Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Osteoarthritis Gene Therapy by Company Revenue
        3.2.2 Top 3 Osteoarthritis Gene Therapy Players Market Share in 2023
        3.2.3 Top 6 Osteoarthritis Gene Therapy Players Market Share in 2023
    3.3 Osteoarthritis Gene Therapy Market: Overall Company Footprint Analysis
        3.3.1 Osteoarthritis Gene Therapy Market: Region Footprint
        3.3.2 Osteoarthritis Gene Therapy Market: Company Product Type Footprint
        3.3.3 Osteoarthritis Gene Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Osteoarthritis Gene Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Osteoarthritis Gene Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Osteoarthritis Gene Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Osteoarthritis Gene Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Osteoarthritis Gene Therapy Consumption Value by Type (2019-2030)
    6.2 North America Osteoarthritis Gene Therapy Consumption Value by Application (2019-2030)
    6.3 North America Osteoarthritis Gene Therapy Market Size by Country
        6.3.1 North America Osteoarthritis Gene Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Osteoarthritis Gene Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Osteoarthritis Gene Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Osteoarthritis Gene Therapy Market Size by Country
        7.3.1 Europe Osteoarthritis Gene Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Osteoarthritis Gene Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Osteoarthritis Gene Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Osteoarthritis Gene Therapy Market Size by Region
        8.3.1 Asia-Pacific Osteoarthritis Gene Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Osteoarthritis Gene Therapy Consumption Value by Type (2019-2030)
    9.2 South America Osteoarthritis Gene Therapy Consumption Value by Application (2019-2030)
    9.3 South America Osteoarthritis Gene Therapy Market Size by Country
        9.3.1 South America Osteoarthritis Gene Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Osteoarthritis Gene Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Osteoarthritis Gene Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Osteoarthritis Gene Therapy Market Size by Country
        10.3.1 Middle East & Africa Osteoarthritis Gene Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Osteoarthritis Gene Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Osteoarthritis Gene Therapy Market Drivers
    11.2 Osteoarthritis Gene Therapy Market Restraints
    11.3 Osteoarthritis Gene Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Osteoarthritis Gene Therapy Industry Chain
    12.2 Osteoarthritis Gene Therapy Upstream Analysis
    12.3 Osteoarthritis Gene Therapy Midstream Analysis
    12.4 Osteoarthritis Gene Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Osteoarthritis Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Osteoarthritis Gene Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Osteoarthritis Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Osteoarthritis Gene Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Flexion Company Information, Head Office, and Major Competitors
    Table 6. Flexion Major Business
    Table 7. Flexion Osteoarthritis Gene Therapy Product and Solutions
    Table 8. Flexion Osteoarthritis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Flexion Recent Developments and Future Plans
    Table 10. GeneQuine Company Information, Head Office, and Major Competitors
    Table 11. GeneQuine Major Business
    Table 12. GeneQuine Osteoarthritis Gene Therapy Product and Solutions
    Table 13. GeneQuine Osteoarthritis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. GeneQuine Recent Developments and Future Plans
    Table 15. Novartis Company Information, Head Office, and Major Competitors
    Table 16. Novartis Major Business
    Table 17. Novartis Osteoarthritis Gene Therapy Product and Solutions
    Table 18. Novartis Osteoarthritis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Novartis Recent Developments and Future Plans
    Table 20. Smith & Nephew Company Information, Head Office, and Major Competitors
    Table 21. Smith & Nephew Major Business
    Table 22. Smith & Nephew Osteoarthritis Gene Therapy Product and Solutions
    Table 23. Smith & Nephew Osteoarthritis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Smith & Nephew Recent Developments and Future Plans
    Table 25. Genascence Company Information, Head Office, and Major Competitors
    Table 26. Genascence Major Business
    Table 27. Genascence Osteoarthritis Gene Therapy Product and Solutions
    Table 28. Genascence Osteoarthritis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Genascence Recent Developments and Future Plans
    Table 30. Kolon TissueGene Company Information, Head Office, and Major Competitors
    Table 31. Kolon TissueGene Major Business
    Table 32. Kolon TissueGene Osteoarthritis Gene Therapy Product and Solutions
    Table 33. Kolon TissueGene Osteoarthritis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Kolon TissueGene Recent Developments and Future Plans
    Table 35. Sanofi Company Information, Head Office, and Major Competitors
    Table 36. Sanofi Major Business
    Table 37. Sanofi Osteoarthritis Gene Therapy Product and Solutions
    Table 38. Sanofi Osteoarthritis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Sanofi Recent Developments and Future Plans
    Table 40. Paraxel Company Information, Head Office, and Major Competitors
    Table 41. Paraxel Major Business
    Table 42. Paraxel Osteoarthritis Gene Therapy Product and Solutions
    Table 43. Paraxel Osteoarthritis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Paraxel Recent Developments and Future Plans
    Table 45. Medipost Company Information, Head Office, and Major Competitors
    Table 46. Medipost Major Business
    Table 47. Medipost Osteoarthritis Gene Therapy Product and Solutions
    Table 48. Medipost Osteoarthritis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Medipost Recent Developments and Future Plans
    Table 50. Mundipharma Company Information, Head Office, and Major Competitors
    Table 51. Mundipharma Major Business
    Table 52. Mundipharma Osteoarthritis Gene Therapy Product and Solutions
    Table 53. Mundipharma Osteoarthritis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Mundipharma Recent Developments and Future Plans
    Table 55. Global Osteoarthritis Gene Therapy Revenue (USD Million) by Players (2019-2024)
    Table 56. Global Osteoarthritis Gene Therapy Revenue Share by Players (2019-2024)
    Table 57. Breakdown of Osteoarthritis Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Osteoarthritis Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 59. Head Office of Key Osteoarthritis Gene Therapy Players
    Table 60. Osteoarthritis Gene Therapy Market: Company Product Type Footprint
    Table 61. Osteoarthritis Gene Therapy Market: Company Product Application Footprint
    Table 62. Osteoarthritis Gene Therapy New Market Entrants and Barriers to Market Entry
    Table 63. Osteoarthritis Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Osteoarthritis Gene Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 65. Global Osteoarthritis Gene Therapy Consumption Value Share by Type (2019-2024)
    Table 66. Global Osteoarthritis Gene Therapy Consumption Value Forecast by Type (2025-2030)
    Table 67. Global Osteoarthritis Gene Therapy Consumption Value by Application (2019-2024)
    Table 68. Global Osteoarthritis Gene Therapy Consumption Value Forecast by Application (2025-2030)
    Table 69. North America Osteoarthritis Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 70. North America Osteoarthritis Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 71. North America Osteoarthritis Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. North America Osteoarthritis Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. North America Osteoarthritis Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 74. North America Osteoarthritis Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 75. Europe Osteoarthritis Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Europe Osteoarthritis Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Europe Osteoarthritis Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 78. Europe Osteoarthritis Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 79. Europe Osteoarthritis Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Osteoarthritis Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Osteoarthritis Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 82. Asia-Pacific Osteoarthritis Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 83. Asia-Pacific Osteoarthritis Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 84. Asia-Pacific Osteoarthritis Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 85. Asia-Pacific Osteoarthritis Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 86. Asia-Pacific Osteoarthritis Gene Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 87. South America Osteoarthritis Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 88. South America Osteoarthritis Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 89. South America Osteoarthritis Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 90. South America Osteoarthritis Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 91. South America Osteoarthritis Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. South America Osteoarthritis Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Middle East & Africa Osteoarthritis Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Osteoarthritis Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 95. Middle East & Africa Osteoarthritis Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 96. Middle East & Africa Osteoarthritis Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Osteoarthritis Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 98. Middle East & Africa Osteoarthritis Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 99. Osteoarthritis Gene Therapy Raw Material
    Table 100. Key Suppliers of Osteoarthritis Gene Therapy Raw Materials
List of Figures
    Figure 1. Osteoarthritis Gene Therapy Picture
    Figure 2. Global Osteoarthritis Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Osteoarthritis Gene Therapy Consumption Value Market Share by Type in 2023
    Figure 4. Synovium Injection
    Figure 5. Cartilage Injection
    Figure 6. Global Osteoarthritis Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Osteoarthritis Gene Therapy Consumption Value Market Share by Application in 2023
    Figure 8. Hospitals and clinics Picture
    Figure 9. Orthopedic Centers Picture
    Figure 10. Assisted living Facilities Picture
    Figure 11. Nursing Homes Picture
    Figure 12. Ambulatory Surgical Centers Picture
    Figure 13. Others Picture
    Figure 14. Global Osteoarthritis Gene Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 15. Global Osteoarthritis Gene Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 16. Global Market Osteoarthritis Gene Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 17. Global Osteoarthritis Gene Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 18. Global Osteoarthritis Gene Therapy Consumption Value Market Share by Region in 2023
    Figure 19. North America Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Europe Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. Asia-Pacific Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. South America Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. Middle East and Africa Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 24. Global Osteoarthritis Gene Therapy Revenue Share by Players in 2023
    Figure 25. Osteoarthritis Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 26. Global Top 3 Players Osteoarthritis Gene Therapy Market Share in 2023
    Figure 27. Global Top 6 Players Osteoarthritis Gene Therapy Market Share in 2023
    Figure 28. Global Osteoarthritis Gene Therapy Consumption Value Share by Type (2019-2024)
    Figure 29. Global Osteoarthritis Gene Therapy Market Share Forecast by Type (2025-2030)
    Figure 30. Global Osteoarthritis Gene Therapy Consumption Value Share by Application (2019-2024)
    Figure 31. Global Osteoarthritis Gene Therapy Market Share Forecast by Application (2025-2030)
    Figure 32. North America Osteoarthritis Gene Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 33. North America Osteoarthritis Gene Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 34. North America Osteoarthritis Gene Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 35. United States Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 36. Canada Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 37. Mexico Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 38. Europe Osteoarthritis Gene Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 39. Europe Osteoarthritis Gene Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 40. Europe Osteoarthritis Gene Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 41. Germany Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 42. France Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 43. United Kingdom Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 44. Russia Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 45. Italy Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 46. Asia-Pacific Osteoarthritis Gene Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 47. Asia-Pacific Osteoarthritis Gene Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 48. Asia-Pacific Osteoarthritis Gene Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 49. China Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 50. Japan Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 51. South Korea Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 52. India Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 53. Southeast Asia Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 54. Australia Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 55. South America Osteoarthritis Gene Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 56. South America Osteoarthritis Gene Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 57. South America Osteoarthritis Gene Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 58. Brazil Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 59. Argentina Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 60. Middle East and Africa Osteoarthritis Gene Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 61. Middle East and Africa Osteoarthritis Gene Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 62. Middle East and Africa Osteoarthritis Gene Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 63. Turkey Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 64. Saudi Arabia Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 65. UAE Osteoarthritis Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 66. Osteoarthritis Gene Therapy Market Drivers
    Figure 67. Osteoarthritis Gene Therapy Market Restraints
    Figure 68. Osteoarthritis Gene Therapy Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Osteoarthritis Gene Therapy in 2023
    Figure 71. Manufacturing Process Analysis of Osteoarthritis Gene Therapy
    Figure 72. Osteoarthritis Gene Therapy Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Companies Mentioned

Flexion
GeneQuine
Novartis
Smith & Nephew
Genascence
Kolon TissueGene
Sanofi
Paraxel
Medipost
Mundipharma